Assessment of Patients With Prostate Cancer and Their Understanding of the International Prostate Symptom Score Questionnaire.

Autor:	Gewanter RM; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Sandhu JS; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York., Tin AL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Gross JP; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Mazzarella K; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Urban J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Elsebai N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Hopkins MF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Jazyk:	angličtina
Zdroj:	Advances in radiation oncology [Adv Radiat Oncol] 2023 Feb 23; Vol. 8 (4), pp. 101200. Date of Electronic Publication: 2023 Feb 23 (Print Publication: 2023).
DOI:	10.1016/j.adro.2023.101200
Abstrakt:	Purpose: The International Prostate Symptom Score (IPSS) is a widely used tool for evaluating patient-reported lower urinary tract symptoms. In this study, we assessed patients with prostate cancer and their understanding of IPSS questions. Methods and Materials: Consecutive patients with prostate cancer (N = 144) self-completed an online IPSS questionnaire within 1 week before their visit at our radiation oncology clinic. At the visit, a nurse reviewed each IPSS question to ensure the patient understood it and then verified the patient's answer. Preverified and nurse-verified scores were recorded and analyzed for discrepancies. Results: Complete concordance between preverified and nurse-verified responses to individual IPSS questions existed for 70 men (49%). In terms of overall IPSS score, 61 men (42%) had a lower or improved IPSS after nurse verification, and 9 men (6%) had a higher or worse IPSS. Before verification, patients overstated their symptoms of frequency, intermittency, and incomplete emptying. As a result of the nurse verification, 4 of 7 patients with IPSS in the severe range (20-35) were recategorized to the moderate range (8-19). Sixteen percent of patients whose preverified IPSS were in the moderate range were recategorized after nurse verification to the mild range (0-7). Treatment option eligibility changed for 10% of patients after nurse verification. Conclusions: Patients frequently misunderstand the IPSS questionnaire, leading them to respond in ways that do not accurately reflect their symptoms. Clinicians should verify patient understanding of the IPSS questions, particularly when using the score to determine eligibility for treatments. (© 2023 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu